JPMORGAN ELECT PLC (the 'Company') | |
Legal Entity Identifier: 549300FIUYKKL39ILD07 | |
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 May 2021 | |
Managed Growth portfolio | |
JPMorgan American Inv Trust | 11.8% |
JPMorgan Claverhouse Inv Trust | 8.2% |
JPM UK Equity Plus C | 8.1% |
JPMorgan UK Dynamic C | 6.7% |
JPMorgan US Equity All Capital C | 6.0% |
Finsbury Growth & Income | 5.5% |
The Mercantile Inv Trust | 4.0% |
Murray Income Trust | 3.9% |
Fidelity | 3.2% |
JPMorgan European Inv Trust (Growth) | 3.0% |
Total | 60.5% |
Managed Income portfolio | |
Royal Dutch Shell | 4.6% |
AstraZeneca | 4.6% |
Rio Tinto | 4.5% |
Barclays | 3.3% |
GlaxoSmithKline | 3.2% |
BP | 3.2% |
OSB | 2.9% |
British American Tobacco | 2.8% |
Computacenter | 2.6% |
Unilever | 2.6% |
Total | 34.3% |
* Based on invested portfolio | |
Name of contact and telephone number for queries: | |
Paul Ainger 0044 207 742 6524 | |
Name of authorised company official responsible for making this notification: | |
Priyanka Vijay Anand 0044 203 493 1504 - Company Secretary | |
Date: 11 June 2021 | |
| |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.